[February 07, 2012]

Golden Valley Development, Inc. Announces Appointment of Leading Dental Materials Scientist to Advisory Board

Golden Valley Development, Inc. (OTC: GVDI) (www.goldenvalleydev.com) is pleased to announce the appointment of John Powers, Ph. D., to its recently-formed Advisory Board. Dr. Powers has been involved in the development of the PercuGuard^TM needlestick prevention device and will be instrumental in ensuring the device's successful near-term introduction into broad dental and medical use in applications where superior protection from exposure to blood borne pathogens is a critical need.

Dr. Powers, an internationally respected dental materials scientist, holds multiple professorships at renowned dental schools in Texas, Michigan, and Germany. He publishes a widely-read dental materials newsletter, The Dental Advisor, and has authored or co-authored over 1,000 scientific articles, textbooks, and othr dental industry publications. Additional information about Dr. Powers is available at www.goldenvalleydev.com/management.

Kevin Sorrels, D.D.S., CEO of GVDI, stated, "We are excited and honored to add John to our Advisory Board, as he has played an instrumental role in the original research and product development that resulted in successful field trials, patent approval and FDA clearance of the first generation Percuguard finger sleeve."

"I am pleased to be able to see this exciting product through to its successful global introduction as it provides a workable solution to the issue of accidental needlesticks in medical applications where other approaches just don't work as well," said Dr. Powers.

GVDI expects to complete final production engineering of the Percuguard needlestick protection sleeve in early 2012, followed by its global introduction into dental, medical and ambulatory applications. Market research indicates that there are an estimated 20 billion potential applications per year for the single-use disposable device.

About Golden Valley Development, Inc.

Golden Valley Development, Inc. is a publicly-traded product development and technology licensing company based in Clearwater, FL. Through two of its wholly-owned subsidiaries, its business plan is to manufacture and market patented products in the health care and home consumer markets, beginning with its first two products, "Cut Stop"^TM and "PercuGuard"^TM.

Forward-Looking Statements

Portions of this press release contain forward-looking statements and involve risks and uncertainties that could materially affect expected results of operations, liquidity, cash flows and business prospects.

[ Back To TMCnet.com's Homepage ]